Rewriting DNA in the body lowers cholesterol.
Science
; 382(6672): 751, 2023 11 17.
Article
in En
| MEDLINE
| ID: mdl-37972155
ABSTRACT
Verve Therapeutics says its base-editing approach may help prevent heart disease in many people.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Genetic Therapy
/
CRISPR-Cas Systems
/
Proprotein Convertase 9
/
Gene Editing
/
Hyperaldosteronism
/
Cholesterol, LDL
Limits:
Humans
Language:
En
Journal:
Science
Year:
2023
Document type:
Article
